UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Review of trials currently testing treatment and prevention of COVID-19

Clinical microbiology and infection, 2020-08, Vol.26 (8), p.988-998

2020

Volltextzugriff (PDF)

The Use of Model-Based Tumor-Size Metrics to Predict Survival

Clinical pharmacology and therapeutics, 2014-08, Vol.96 (2), p.133-135

2014

Volltextzugriff (PDF)

Bacteraemia caused by third-generation cephalosporin-resistant Escherichia coli in France: prevalence, molecular epidemiology and clinical features

Clinical microbiology and infection, 2011-04, Vol.17 (4), p.557-565

2011

Volltextzugriff (PDF)

High acquisition rate of extended-spectrum β-lactamase-producing Enterobacteriaceae among French military personnel on mission abroad, without evidence of inter-individual transmission

Clinical microbiology and infection, 2019-05, Vol.25 (5), p.631.e1-631.e9

2019

Volltextzugriff (PDF)

Effect of Adherence as Measured by MEMS, Ritonavir Boosting, and CYP3A5 Genotype on Atazanavir Pharmacokinetics in Treatment-Naive HIV-Infected Patients

Clinical pharmacology and therapeutics, 2012-11, Vol.92 (5), p.575-583

2012

Volltextzugriff (PDF)

Determinants of macroscopic anal cancer and precancerous lesions in 1206 HIV-infected screened patients

Colorectal disease, 2016-10, Vol.18 (10), p.997-1004

2016

Volltextzugriff (PDF)

Pharmacokinetic Similarity of Biologics: Analysis Using Nonlinear Mixed-Effects Modeling

Clinical pharmacology and therapeutics, 2012-02, Vol.91 (2), p.234-242

2012

Volltextzugriff (PDF)

Overview of model‐building strategies in population PK/PD analyses: 2002–2004 literature survey

British journal of clinical pharmacology, 2007-11, Vol.64 (5), p.603-612

2007

Volltextzugriff (PDF)

Escherichia coli bacteraemia in pregnant women is life-threatening for foetuses

Clinical microbiology and infection, 2014-12, Vol.20 (12), p.O1035-O1041

2014

Volltextzugriff (PDF)

The ISoP Standards and Best Practices Committee

Clinical pharmacology and therapeutics, 2014-06, Vol.95 (6), p.581-582

2014

Volltextzugriff (PDF)

A Pharmacokinetic-Viral Kinetic Model Describes the Effect of Alisporivir as Monotherapy or in Combination With Peg-IFN on Hepatitis C Virologic Response

Clinical pharmacology and therapeutics, 2014-11, Vol.96 (5), p.599-608

2014

Volltextzugriff (PDF)

Factors associated with clinical and virological response in patients treated with oseltamivir or zanamivir for influenza A during the 2008–2009 winter

Clinical microbiology and infection, 2013-02, Vol.19 (2), p.196-203

2013

Volltextzugriff (PDF)

Octreotide treatment of idiopathic pulmonary fibrosis: a proof-of-concept study

The European respiratory journal, 2012-03, Vol.39 (3), p.772-775

2012

Volltextzugriff (PDF)

Pharmacokinetic and Pharmacodynamic Variability of Fluindione in Octogenarians

Clinical pharmacology and therapeutics, 2012-05, Vol.91 (5), p.777-786

2012

Volltextzugriff (PDF)

Determination of indinavir and nelfinavir trough plasma concentration efficacy thresholds according to virological response in HIV‐infected patients

HIV medicine, 2004-07, Vol.5 (4), p.307-313

2004

Volltextzugriff (PDF)

Population pharmacokinetic analysis for nelfinavir and its metabolite M8 in virologically controlled HIV‐infected patients on HAART

British journal of clinical pharmacology, 2005-10, Vol.60 (4), p.390-403

2005

Volltextzugriff (PDF)

Population pharmacokinetics of clozapine evaluated with the nonparametric maximum likelihood method

British journal of clinical pharmacology, 1997-11, Vol.44 (5), p.447-453

1997

Volltextzugriff (PDF)

Effect of CYP2C19 polymorphism on nelfinavir to M8 biotransformation in HIV patients

British journal of clinical pharmacology, 2008-04, Vol.65 (4), p.548-557

2008

Volltextzugriff (PDF)

Dose Rationale for Favipiravir Use in Patients Infected With SARS-CoV-2: Clin Pharmacol Ther

Clinical pharmacology and therapeutics, 2020, Vol.108 (2)

2020

Volltextzugriff (PDF)

Population pharmacokinetic-pharmacodynamic analysis of fluindione in patients

Clinical pharmacology and therapeutics, 1998-01, Vol.63 (1), p.64-78

1998

Volltextzugriff (PDF)

Population pharmacokinetics of nortriptyline during monotherapy and during concomitant treatment with drugs that inhibit CYP2D6‐an evaluation with the nonparametric maximum likelihood method

British journal of clinical pharmacology, 1994-11, Vol.38 (5), p.453-462

1994

Volltextzugriff (PDF)

Benefit of therapeutic drug monitoring of protease inhibitors in HIV-infected patients depends on PI used in HAART regimen - ANRS 111 trial

Fundamental & clinical pharmacology, 2009-08, Vol.23 (4), p.491-500

2009

Volltextzugriff (PDF)

Risk factors for Staphylococcus aureus infection in liver transplant recipients

Liver transplantation, 2005-09, Vol.11 (9), p.1093-1099

2005

Volltextzugriff (PDF)

Bayesian estimation of cyclosporin exposure for routine therapeutic drug monitoring in kidney transplant patients

British journal of clinical pharmacology, 2005-01, Vol.59 (1), p.18-27

2005

Volltextzugriff (PDF)

Cerebral uptake of mefloquine enantiomers with and without the P‐gp inhibitor elacridar (GF1210918) in mice

British journal of pharmacology, 2004-04, Vol.141 (7), p.1214-1222

2004

Volltextzugriff (PDF)

1 – 25 von 41

Suche als RSS-Feed

Aktive Filter

KollektionTaylor & Francis:Master (3349 titles)

Zeitschrift / SerieCpt: Pharmacometrics And Systems Pharmacology

ThemaPhysical Sciences

KollektionWiley Online Library Journals Frontfile Complete

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(37)
Mit Volltextzugriff
(40)

Publikationsform

Artikel
(39)
Tagungsberichte
(2)

Sprache

Englisch
(41)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Review of trials currently testing treatment and prevention of COVID-19

The Use of Model-Based Tumor-Size Metrics to Predict Survival

Bacteraemia caused by third-generation cephalosporin-resistant Escherichia coli in France: prevalence, molecular epidemiology and clinical features

High acquisition rate of extended-spectrum β-lactamase-producing Enterobacteriaceae among French military personnel on mission abroad, without evidence of inter-individual transmission

Effect of Adherence as Measured by MEMS, Ritonavir Boosting, and CYP3A5 Genotype on Atazanavir Pharmacokinetics in Treatment-Naive HIV-Infected Patients

Determinants of macroscopic anal cancer and precancerous lesions in 1206 HIV-infected screened patients

Pharmacokinetic Similarity of Biologics: Analysis Using Nonlinear Mixed-Effects Modeling

Overview of model‐building strategies in population PK/PD analyses: 2002–2004 literature survey

Escherichia coli bacteraemia in pregnant women is life-threatening for foetuses

The ISoP Standards and Best Practices Committee

A Pharmacokinetic-Viral Kinetic Model Describes the Effect of Alisporivir as Monotherapy or in Combination With Peg-IFN on Hepatitis C Virologic Response

Factors associated with clinical and virological response in patients treated with oseltamivir or zanamivir for influenza A during the 2008–2009 winter

Octreotide treatment of idiopathic pulmonary fibrosis: a proof-of-concept study

Pharmacokinetic and Pharmacodynamic Variability of Fluindione in Octogenarians

Determination of indinavir and nelfinavir trough plasma concentration efficacy thresholds according to virological response in HIV‐infected patients

Population pharmacokinetic analysis for nelfinavir and its metabolite M8 in virologically controlled HIV‐infected patients on HAART

Population pharmacokinetics of clozapine evaluated with the nonparametric maximum likelihood method

Effect of CYP2C19 polymorphism on nelfinavir to M8 biotransformation in HIV patients

Dose Rationale for Favipiravir Use in Patients Infected With SARS-CoV-2: Clin Pharmacol Ther

Population pharmacokinetic-pharmacodynamic analysis of fluindione in patients

Population pharmacokinetics of nortriptyline during monotherapy and during concomitant treatment with drugs that inhibit CYP2D6‐an evaluation with the nonparametric maximum likelihood method

Benefit of therapeutic drug monitoring of protease inhibitors in HIV-infected patients depends on PI used in HAART regimen - ANRS 111 trial

Risk factors for Staphylococcus aureus infection in liver transplant recipients

Bayesian estimation of cyclosporin exposure for routine therapeutic drug monitoring in kidney transplant patients

Cerebral uptake of mefloquine enantiomers with and without the P‐gp inhibitor elacridar (GF1210918) in mice

Aktive Filter

Suchergebnisse filtern